PCB vs REGN · P/E 11, rev $2.8M vs P/E 14, rev $14.34B
PCB Bancorp (PCB) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
PCB Bancorp (PCB) is a banks - regional company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported PCB revenue for 2024-12-31 was $2.8M. Net income was $25.8M. Revenue was up 4.7% from 2023-12-31 to 2024-12-31. PCB currently screens at market cap $308.8M and trailing P/E 10.8.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
PCB currently screens at market cap $308.8M and trailing P/E 10.8. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the PCB and REGN stock pages for the full models.
Not investment advice.